Article Detail - JE Part B
Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease - R3 - Effective July 01, 2021
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Effective Date: July 01, 2021
Summary of Article Changes:
Under CMS National Coverage Policy moved CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15 §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests to the related LCD.
Under ICD-10 Codes that Support Medical Necessity Group 1: Codes deleted D46.20, D46.4, D46.9, D47.9, D72.829, and D75.9.
Visit the Molecular Diagnostic Services (MolDX) webpage to access the locally hosted MolDX Medicare Coverage Article from the “Covered Tests” or the “Excluded Tests” webpage.
To view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.
Last Updated Mon, 28 Jun 2021 19:02:39 +0000